0001209191-22-012743.txt : 20220224 0001209191-22-012743.hdr.sgml : 20220224 20220224170444 ACCESSION NUMBER: 0001209191-22-012743 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220223 FILED AS OF DATE: 20220224 DATE AS OF CHANGE: 20220224 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kornfeld Steven CENTRAL INDEX KEY: 0001814653 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38052 FILM NUMBER: 22672214 MAIL ADDRESS: STREET 1: C/O FORTE BIOSCIENCES, INC. STREET 2: 1124 W. CARSON ST., MRL BLDG 3-320 CITY: TORRANCE STATE: CA ZIP: 90502 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Forte Biosciences, Inc. CENTRAL INDEX KEY: 0001419041 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 261243872 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1124 W CARSON STREET STREET 2: MRL BUILDING 3-320 CITY: TORRANCE STATE: CA ZIP: 90502 BUSINESS PHONE: (310) 618-6994 MAIL ADDRESS: STREET 1: 1124 W CARSON STREET STREET 2: MRL BUILDING 3-320 CITY: TORRANCE STATE: CA ZIP: 90502 FORMER COMPANY: FORMER CONFORMED NAME: Tocagen Inc DATE OF NAME CHANGE: 20071120 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-02-23 0 0001419041 Forte Biosciences, Inc. FBRX 0001814653 Kornfeld Steven C/O FORTE BIOSCIENCES, INC. 3060 PEGASUS PARK DR., BUILDING 6 DALLAS TX 75247 1 0 0 0 Stock Option (right to buy) 1.27 2022-02-23 4 A 0 25000 0.00 A 2032-02-23 Common Stock 25000 25000 D Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2021 Equity Incentive Plan) through the applicable vesting date, one hundred percent (100%) of the shares subject to the option shall vest on the one (1) year anniversary of the Date of Grant. "Date of Grant" shall mean February 23, 2022. /s/ Paul A. Wagner, Ph.D., as Attorney-in-Fact 2022-02-24